Impact of BCL2 polymorphisms on survival in transitional cell carcinoma of the bladder

被引:0
|
作者
Jochen Hess
Patrick Stelmach
Andreas Eisenhardt
Herbert Rübben
Henning Reis
Kurt Werner Schmid
Hagen Sjard Bachmann
机构
[1] University Hospital Essen,Clinic of Urology
[2] University of Duisburg-Essen,Institute of Pharmacogenetics
[3] University Hospital Essen,Institute of Pathology
[4] University of Duisburg-Essen,undefined
[5] Praxisklinik Urologie Rhein/Ruhr,undefined
[6] University Hospital Essen,undefined
[7] University of Duisburg-Essen,undefined
关键词
BCL2; Bladder cancer; Urothelial carcinoma; Single-nucleotide polymorphism; SNP;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1659 / 1670
页数:11
相关论文
共 50 条
  • [1] Impact of BCL2 polymorphisms on survival in transitional cell carcinoma of the bladder
    Hess, Jochen
    Stelmach, Patrick
    Eisenhardt, Andreas
    Ruebben, Herbert
    Reis, Henning
    Schmid, Kurt Werner
    Bachmann, Hagen Sjard
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2017, 143 (09) : 1659 - 1670
  • [2] BCL2 expression predicts survival in patients receiving synchronous chemoradiotherapy in advanced transitional cell carcinoma of the bladder
    Hussain, SA
    Ganesan, R
    Hiller, L
    Cooke, PW
    Murray, P
    Young, LS
    James, ND
    [J]. ONCOLOGY REPORTS, 2003, 10 (03) : 571 - 576
  • [3] Effect of DAPK methylation and Bcl2 over expression on risk of recurrence in Transitional Cell Carcinoma of bladder
    Motlagh, Fatemeh Zafarghandi
    Fard, Nazanin Arjomand
    Majidizadeh, Tayebeh
    Asgari, Mojgan
    Abolhasani, Maryam
    Shahshahanipour, Majid
    Kamali, Koosha
    Ghadakzadeh, Saleh
    Hosseini, Seyed Ali
    [J]. JOURNAL OF BIOLOGICAL RESEARCH-THESSALONIKI, 2013, 19 : 56 - 64
  • [4] The impact of marital status on the survival of transitional cell carcinoma of the bladder
    Saad, Anas M.
    Baidoun, Firas
    Gad, Mohamed M.
    Ruhban, Inas A.
    Jazieh, Khalid
    Al-Husseini, Muneer J.
    Ornstein, Moshe Chaim
    Rini, Brian I.
    Gupta, Shilpa
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [5] Does a prior malignancy impact the survival of transitional cell carcinoma of the bladder?
    Alkhayat, Mohamad A.
    Saad, Anas M.
    Gad, Mohamed M.
    Obaid, Mariam A.
    Salahia, Sami
    Arwani, Remy
    Al-Husseini, Muneer J.
    [J]. ANNALS OF ONCOLOGY, 2018, 29
  • [6] The impact of comorbidity on survival in a cystectomy series for transitional cell carcinoma of the bladder
    Volkmer, Bjoern G.
    Kron, Martina
    Froeba, Gebhard
    Hautmann, Richard E.
    [J]. JOURNAL OF UROLOGY, 2008, 179 (04): : 529 - 529
  • [7] Immunohistochemical analysis of bcl-2 expression in transitional cell carcinoma of the bladder
    Shiina, H
    Igawa, M
    Urakami, S
    Honda, S
    Shirakawa, H
    Ishibe, T
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 1996, 49 (05) : 395 - 399
  • [8] Quantitative methylation-specific PCR of DAPK, BCL2 and HTERT genes in urine sediments of patients with transitional cell carcinoma of the bladder
    Selh, C.
    Kuncova, J.
    Villari, D.
    Vinci, S.
    Orlando, C.
    [J]. EUROPEAN UROLOGY SUPPLEMENTS, 2008, 7 (03) : 208 - 208
  • [9] Transitional cell carcinoma of the bladder: Recurrence, progression and survival
    McHugh, LA
    Griffiths, TRL
    [J]. BJU INTERNATIONAL, 2004, 94 (01) : 193 - 193
  • [10] HLA-G polymorphisms in the bladder transitional cell carcinoma
    Castelli, Erick C.
    Mendes-Junior, Celso T.
    Simoes, Renata T.
    de Camargo, Joao Lauro V.
    Donadi, Eduardo A.
    [J]. HUMAN IMMUNOLOGY, 2006, 67 (10) : S122 - S122